Ireland

JSC «Grindeks» started operation in Ireland in 2001 by exporting active pharmaceutical ingredient zopiclone.

«Grindeks» produces and sells active pharmaceutical ingredient zopiclone to the Irish company "Gerard Laboratories". Development of the zopiclone manufacturing technologies after the request of the partner was finished in 1997, and «Grindeks» was one of the first manufacturers of this generic substance.